Natco Pharma has announced the launch of a new generic drug in the United States, strengthening its presence in one of the world’s most lucrative pharmaceutical markets. The move underscores the company’s strategy to enhance global accessibility to affordable medications while diversifying its international portfolio. By introducing this generic alternative, Natco aims to capture market share in a highly competitive landscape dominated by established players.